Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDXBiotech Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2026 | 1 | $0.03 | $0.03 | $0.03 |
| Q3 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2026 | 1 | $0.04 | $0.04 | $0.04 |
| Q1 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q3 2027 | 1 | $0.02 | $0.02 | $0.02 |
XBiotech Inc Earnings Date And Information
XBiotech Inc last posted its earnings results on Tuesday, March 15th, 2022. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.23. The company had revenue of 0 for the quarter and had revenue of 0 for the year. XBiotech Inc has generated $-1 earnings per share over the last year ($-1.26 diluted earnings per share) and currently has a price-to-earnings ratio of -2.49. XBiotech Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
XBiotech Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | N/A | -$0.20 | N/A | $7.00 M | $0 |
| 08/13/2025 | Q2 2025 | N/A | -$0.06 | N/A | $7.00 M | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$0.36 | N/A | N/A | $0 |
| 04/29/2025 | Q4 2024 | N/A | -$0.34 | N/A | N/A | $0 |
| 11/13/2024 | Q3 2024 | N/A | -$0.16 | N/A | $7.00 M | $0 |
| 08/12/2024 | Q2 2024 | N/A | -$0.43 | N/A | $7.00 M | $0 |
| 05/10/2024 | Q1 2024 | N/A | -$0.33 | N/A | N/A | $0 |
| 05/01/2024 | Q4 2023 | N/A | -$0.15 | N/A | N/A | $0 |
| 11/09/2023 | Q3 2023 | N/A | -$0.24 | N/A | N/A | $0 |
| 08/11/2023 | Q2 2023 | N/A | -$0.29 | N/A | N/A | $0 |
| 05/10/2023 | Q1 2023 | N/A | -$0.13 | N/A | N/A | $0 |
| 03/15/2023 | Q4 2022 | N/A | -$0.11 | N/A | N/A | $300.00 K |
| 11/09/2022 | Q3 2022 | N/A | -$0.42 | N/A | N/A | $1.68 M |
| 08/09/2022 | Q2 2022 | N/A | -$0.38 | N/A | N/A | $1.53 M |
| 05/10/2022 | Q1 2022 | N/A | -$0.18 | N/A | N/A | $500.00 K |
| 03/15/2022 | Q4 2021 | $0.02 | -$0.21 | -0.23 | N/A | $4.50 M |
| 11/09/2021 | Q3 2021 | $0.03 | -$0.11 | -0.14 | N/A | $4.52 M |
| 08/09/2021 | Q2 2021 | $0.03 | -$0.17 | -0.2 | N/A | $4.53 M |
| 05/10/2021 | Q1 2021 | $0.04 | -$0.09 | -0.13 | N/A | $4.85 M |
| 03/16/2021 | Q4 2020 | $0.04 | -$0.06 | -0.1 | N/A | $5.27 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
XBiotech Inc Earnings: FAQ's
The conference call for XBiotech Inc's latest earnings report can be listened to online.
The conference call transcript for XBiotech Inc's latest earnings report can be read online.
XBiotech Inc (:XBIT) has a recorded net income of $-38,531,000.XBiotech Inc has generated $-1.26 earnings per share over the last four quarters.
XBiotech Inc (:XBIT) has a price-to-earnings ratio of -2.49 and price/earnings-to-growth ratio is 0.57.